American International Group’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-58,847	Closed	-$1.21M	–	765
2024 Q1	$1.21M	Buy	58,847 +122	+0.2%	+$2.29K	﹤0.01%	1206
2023 Q4	$1.26M	Sell	58,725 -237	-0.4%	-$4.69K	0.01%	1186
2023 Q3	$1.22M	Buy	58,962 +2,096	+4%	+$53.2K	0.01%	1147
2023 Q2	$1.68M	Buy	56,866 +4,336	+8%	+$122K	0.01%	1018
2023 Q1	$1.21M	Buy	52,530 +1,046	+2%	+$28.8K	0.01%	1145
2022 Q4	$1.43M	Buy	51,484 +4,707	+10%	+$140K	0.01%	1049
2022 Q3	$1.44M	Buy	46,777 +661	+1%	+$21.5K	0.01%	1037
2022 Q2	$1.36M	Buy	46,116 +945	+2%	+$24.8K	0.01%	1077
2022 Q1	$1.45M	Sell	45,171 -3,179	-7%	-$109K	0.01%	1143
2021 Q4	$2.16M	Sell	48,350 -1,447	-3%	-$68.6K	0.01%	1044
2021 Q3	$2.51M	Sell	49,797 -1,183	-2%	-$66.7K	0.01%	965
2021 Q2	$4K	Buy	50,980 +12,457	+32%	+$771K	0.01%	897
2021 Q1	$2.2K	Sell	38,523 -151	-0.4%	-$10.1K	0.01%	1072
2020 Q4	$3.24K	Buy	38,674 +1,071	+3%	+$64.7K	0.01%	920
2020 Q3	$1.35M	Sell	37,603 -856	-2%	-$25.8K	0.01%	1111
2020 Q2	$930K	Buy	38,459 +7,594	+25%	+$179K	﹤0.01%	1263
2020 Q1	$540K	Buy	30,865 +840	+3%	+$17.5K	﹤0.01%	1385
2019 Q4	$523K	Sell	30,025 -252	-0.8%	-$4.2K	﹤0.01%	1668
2019 Q3	$464K	Sell	30,277 -211	-0.7%	-$4.03K	﹤0.01%	1705
2019 Q2	$633K	Buy	30,488 +1,430	+5%	+$32K	﹤0.01%	1570
2019 Q1	$675K	Sell	29,058 -942	-3%	-$19.7K	﹤0.01%	1543
2018 Q4	$620K	Sell	30,000 -231	-0.8%	-$4.19K	﹤0.01%	1547
2018 Q3	$657K	Buy	30,231 +19,217	+174%	+$318K	﹤0.01%	1711
2018 Q2	$168K	Buy	11,014 +697	+7%	+$13.1K	﹤0.01%	2465
2018 Q1	$203K	Buy	+10,317	New	+$212K	﹤0.01%	2253